Savannah Neurology Specialists is proud to offer groundbreaking, FDA-approved therapies for mild Alzheimer’s disease, Leqembi (lecanemab) and Kisunla (donanemab), providing new hope to our community. These treatments are designed to target amyloid plaques, a hallmark of Alzheimer’s, with the goal of slowing disease progression and preserving cognitive function for a longer period. By infusing these innovative therapies, we are committed to bringing cutting-edge care to patients and families affected by Alzheimer’s, helping to improve quality of life and offer hope for the future. Our advancements in Alzheimer’s care were recently featured on PBS' Your Fantastic Mind! Check out the link below to view our segment and learn more about how we are making a difference in the fight against Alzheimer’s disease: